| Dr Sharon C Amaya, MD | |
|
600 W Memorial Dr, Dallas, GA 30132-4117 | |
| (770) 443-7072 | |
| Not Available |
| Full Name | Dr Sharon C Amaya |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 600 W Memorial Dr, Dallas, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326151861 | NPI | - | NPPES |
| 00834226C | Medicaid | GA | |
| 00834226F | Medicaid | GA | |
| 00834226E | Medicaid | GA | |
| 119369000 | Other | GA | DOL |
| 00834226D | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 047182 (Georgia) | Primary |
| Entity Name | The Bortolazzo Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801965082 PECOS PAC ID: 3476554320 Enrollment ID: O20070122000015 |
News Archive
A new study by Yale Cancer Center and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
AMRI today announced the selection of a compound from its proprietary research program for the treatment of irritable bowel syndrome (IBS) for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) in 2011.
New data were presented today at the 18th International AIDS Conference from the VERxVE study that show an investigational, once-daily extended-release (400 mg QD) formulation of nevirapine was non-inferior to twice-daily immediate release Viramune® (nevirapine) tablets (200 mg BID), both in combination with Truvada® (tenofovir and emtricitabine) tablets in treatment-naive HIV-1 infected patients through 48 weeks.
The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point of sale.
A new paper published on the preprint server medRxiv* in May 2020 suggests that India could be facing the end of a relatively mild outbreak of COVID-19 compared with many other countries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon C Amaya, MD 5665 New Northside Dr Nw, Suite 320, Atlanta, GA 30328-5831 Ph: (770) 874-5400 | Dr Sharon C Amaya, MD 600 W Memorial Dr, Dallas, GA 30132-4117 Ph: (770) 443-7072 |
News Archive
A new study by Yale Cancer Center and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
AMRI today announced the selection of a compound from its proprietary research program for the treatment of irritable bowel syndrome (IBS) for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) in 2011.
New data were presented today at the 18th International AIDS Conference from the VERxVE study that show an investigational, once-daily extended-release (400 mg QD) formulation of nevirapine was non-inferior to twice-daily immediate release Viramune® (nevirapine) tablets (200 mg BID), both in combination with Truvada® (tenofovir and emtricitabine) tablets in treatment-naive HIV-1 infected patients through 48 weeks.
The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point of sale.
A new paper published on the preprint server medRxiv* in May 2020 suggests that India could be facing the end of a relatively mild outbreak of COVID-19 compared with many other countries.
› Verified 2 days ago
Dr. Curtis Cheeks Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 51 Seven Hills Blvd, Suite 102, Dallas, GA 30132 Phone: 678-574-3000 Fax: 678-574-3001 |